Stifel Financial Portfolio holdings
AUM
$103B
1-Year Return
17.55%
This Quarter Return
+2.12%
1 Year Return
+17.55%
3 Year Return
+67.43%
5 Year Return
+118.9%
10 Year Return
+263.91%
AUM
$88.9B
AUM Growth
+$1.09B
(+1.2%)
Cap. Flow
+$347M
Cap. Flow
% of AUM
0.39%
Top 10 Holdings %
Top 10 Hldgs %
17.04%
Holding
3,492
New
156
Increased
1,624
Reduced
1,484
Closed
128
Top Buys
| 1 |
Apple
AAPL
|
+$76.8M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$74.6M |
| 3 |
Lincoln Electric
LECO
|
+$70.6M |
| 4 |
SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$68.7M |
| 5 |
Exxon Mobil
XOM
|
+$67.8M |
Top Sells
| 1 |
Intel
INTC
|
+$111M |
| 2 |
NVIDIA
NVDA
|
+$111M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$71.6M |
| 4 |
Unilever
UL
|
+$61.6M |
| 5 |
SPDR S&P 400 Mid Cap Growth ETF
MDYG
|
+$58.8M |
Sector Composition
| 1 | Technology | 20.01% |
| 2 | Industrials | 9.72% |
| 3 | Healthcare | 9.37% |
| 4 | Financials | 8.21% |
| 5 | Consumer Staples | 7.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3251
The RealReal
REAL
$1.02B
| $66.1K | ﹤0.01% |
20,731
+5,800
| +39% | +$18.5K |
|
|
CYBN
3252
Cybin
CYBN
$148M
| $66K | ﹤0.01% |
6,414
| – | – |
|
3253
3D Systems Corporation
DDD
$272M
| $65.8K | ﹤0.01% |
21,427
+2,284
| +12% | +$7.01K |
|
3254
Conduent
CNDT
$442M
| $65.5K | ﹤0.01% |
20,077
+71
| +0.4% | +$231 |
|
3255
Comtech Telecommunications
CMTL
$65.3M
| $65.3K | ﹤0.01% |
21,564
-169
| -0.8% | -$512 |
|
3256
Esperion Therapeutics
ESPR
$524M
| $64.2K | ﹤0.01% |
28,915
-120
| -0.4% | -$266 |
|
|
TSI
3257
TCW Strategic Income Fund
TSI
$238M
| $62.3K | ﹤0.01% |
13,146
+34
| +0.3% | +$161 |
|
3258
Grab
GRAB
$21.6B
| $61.6K | ﹤0.01% |
17,353
+1,000
| +6% | +$3.55K |
|
3259
Pacific Biosciences
PACB
$366M
| $61K | ﹤0.01% |
44,559
-11,515
| -21% | -$15.8K |
|
3260
Dynagas LNG Partners
DLNG
$139M
| $59.6K | ﹤0.01% |
+14,800
| New | +$59.6K |
|
3261
Absci
ABSI
$356M
| $58.3K | ﹤0.01% |
18,927
-2,135
| -10% | -$6.58K |
|
3262
Marqeta
MQ
$2.64B
| $58.1K | ﹤0.01% |
+10,595
| New | +$58.1K |
|
|
AWP
3263
abrdn Global Premier Properties Fund
AWP
$347M
| $57.5K | ﹤0.01% |
15,046
-1,453
| -9% | -$5.55K |
|
3264
CytomX Therapeutics
CTMX
$341M
| $57.5K | ﹤0.01% |
+47,100
| New | +$57.5K |
|
3265
Hecla Mining
HL
$7.35B
| $57.3K | ﹤0.01% |
11,806
+633
| +6% | +$3.07K |
|
3266
Gerdau
GGB
$6.19B
| $57.1K | ﹤0.01% |
17,292
+5,292
| +44% | +$17.5K |
|
3267
Compass
COMP
$4.83B
| $56.6K | ﹤0.01% |
15,715
+537
| +4% | +$1.93K |
|
3268
Champions Oncology
CSBR
$88.8M
| $56.6K | ﹤0.01% |
10,942
-250
| -2% | -$1.29K |
|
3269
Alto Ingredients
ALTO
$89M
| $56.1K | ﹤0.01% |
38,800
| – | – |
|
|
CXE
3270
MFS High Income Municipal Trust
CXE
$116M
| $55.9K | ﹤0.01% |
15,061
-2,057
| -12% | -$7.63K |
|
3271
Verastem
VSTM
$608M
| $55.7K | ﹤0.01% |
18,697
+1,394
| +8% | +$4.16K |
|
3272
WideOpenWest
WOW
$440M
| $54.3K | ﹤0.01% |
10,037
+37
| +0.4% | +$200 |
|
3273
RAPT Therapeutics
RAPT
$234M
| $53.1K | ﹤0.01% |
+2,178
| New | +$53.1K |
|
3274
E.W. Scripps
SSP
$246M
| $51.4K | ﹤0.01% |
+16,372
| New | +$51.4K |
|
3275
Aldeyra Therapeutics
ALDX
$333M
| $51.4K | ﹤0.01% |
+15,517
| New | +$51.4K |
|